The World Health Organization (WHO) on Monday called on China to provide data and access to help uncover the origins of Covid-19, five years after the pandemic began and disrupted the world.
Covid-19 claimed millions of lives, devastated economies, and overwhelmed healthcare systems globally.
“We continue to call on China to share data and grant access so we can better understand the origins of Covid-19. This is both a moral and scientific imperative,” the WHO stated.
“Without transparency, sharing, and international cooperation, the world cannot effectively prevent or prepare for future epidemics and pandemics.”
Reflecting on the Pandemic’s Start
The WHO recounted how its China office first detected a media statement on December 31, 2019, from Wuhan health authorities reporting cases of “viral pneumonia.”
“In the weeks, months, and years that followed, Covid-19 profoundly reshaped our lives and our world,” the organisation said.
“As we mark this milestone, let us honour those whose lives were changed or lost, recognise those suffering from Covid-19 and Long Covid, express gratitude to health workers who sacrificed so much, and commit to learning from this crisis to build a healthier future.”
Are We Better Prepared?
Earlier this month, WHO Director-General Tedros Adhanom Ghebreyesus reflected on whether the world is better equipped to face the next pandemic.
“The answer is both yes and no,” he said during a press briefing.
“If a pandemic struck today, the world would still face some of the same vulnerabilities that allowed Covid-19 to take hold five years ago.
“However, we have also learned painful lessons and made significant strides in strengthening global defences against future health crises.”
Pandemic Treaty Challenges
In December 2021, spurred by the devastation of Covid-19, countries began drafting an international treaty on pandemic prevention, preparedness, and response.
While WHO’s 194 member states have reached consensus on much of the treaty, key issues remain unresolved.
A primary sticking point involves the obligation to rapidly share emerging pathogens and the benefits derived from them, such as vaccines and treatments.
This divide pits wealthier nations with strong pharmaceutical sectors against lower-income countries concerned about equitable access during future pandemics.
The deadline for finalising the treaty negotiations is May 2025.